Researchers from Wageningen University & Research and Van Andel Institute used a variant of CRISPR, a gene-editing tool, to ...

By Karen Roman SkylineDx said it can predict metastases and outperform existing staging systems for the country’s second most common type of skin cancer, Cutaneous Squamous Cell Carcinoma (CSCC). The ...

The MarketWatch News Department was not involved in the creation of this content.-- Precede Bio Insight debuts as a first-of-its-kind product enabling genome-wide inference of gen ...

SkylineDx, an innovative company specializing in molecular diagnostics for dermatology, today announced the latest research on the company's precision molecular diagnostics advances, including a new ...

Despite spanning about three billion base pairs, the human genome is wrapped up tight in a highly organized fashion in the nucleus. This coordinated structure, in part, enables the cell to regulate ...

A new study from Karolinska Institutet shows that gene analysis of breast cancer tumors can identify patients who do not ...

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...

Rutgers University researchers find that certain aging immune T cells can blunt cell expansion and may help explain why many ...

(This April 1 Health Rounds has been corrected to change ‘genetic’ to ‘genomic’ in the headline and the first item of the ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...